- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03039400
Physiotherapist-guided Home Exercise in Moderate to Severe MS
April 7, 2021 updated by: Katherine Knox, University of Saskatchewan
Physiotherapist-guided Home Exercise in Moderate to Severe Multiple Sclerosis
Physical activity is a crucial component to wellness and is associated with multiple health benefits.
Persons with MS may find it challenging to participate in regular physical activity or exercise, which is activity done to improve health and/or fitness.
This research will test an innovative web-based intervention to help persons with moderate-to-severe disability manage their condition through a maintenance exercise program with specialized physiotherapist guidance and support.
The researchers will examine adherence to the web-based physiotherapy program compared to standard physiotherapy care.
Forty-five people with MS will be randomly assigned to the web group or standard care group at a rate of 2:1.
Participants in the web group will receive supported and individualized web-based physiotherapy.
Participants in the standard care group will receive a written exercise program.
Regular participation (adherence) in the exercise programs will be evaluated in both groups over six months.
The research will also examine participant satisfaction with the programs, safety, MS symptoms, and physical function.
A web-based approach may be widely accessible to persons with MS in their own homes and could support long-term participation in physical activity important to wellness.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
48
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Saskatchewan
-
Saskatoon, Saskatchewan, Canada, S7K 0M7
- Department of Physical Medicine & Rehabilitation, University of Saskatchewan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- diagnosed with MS
- moderate to severe disability (PDDS 2-7)
- able to access the internet in your current living environment
Exclusion Criteria:
- already doing structured exercise more than once per week
- residing >300km from Saskatoon (unless able to travel to Saskatoon for the appointments)
- unable to understand the intent and process of this study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Web-based physio group
Those in the web-based physio group will have an individual exercise program set up by a treating physiotherapist on webbasedphysio.com
after an initial face-to-face assessment.
They will be encouraged to undertake their exercise program at least twice per week and diarize their work.
Participants will receive a weekly phone call from their treating physiotherapist for the first two weeks.
The treating physiotherapist will review the exercise diary of each participant every two weeks, and remotely alter the participant's exercise program as appropriate, by changing exercises, level of difficulty or number of repetitions.
|
Those in the web-based physio group will access their exercise program online and will be able to leave messages for their physiotherapist on the platform.
Physiotherapists will monitor usage and respond to messages every two weeks.
|
Active Comparator: Standard care group
Those in the standard care group will have their exercise program explained to them at an initial face-to-face assessment with a treating physiotherapist as per usual care.
They will receive a written, home-based exercise program.
Participants in the usual care group will also be encouraged to undertake their exercise program at least twice per week, and will be asked to keep an exercise diary, in paper format.
Participants in the usual care group will also receive a weekly phone call from the physiotherapist for the first two weeks to check on progress.
|
Those in the standard care group will receive a written, home-based exercise program.
Participants in the usual care group will be asked to keep an exercise diary, in paper format.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adherence to prescribed exercise program
Time Frame: 6 months
|
Measured by number of completed exercise sessions on exercise diary
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Injury or fall
Time Frame: 6 months
|
Participants will be asked to contact their treating physiotherapist in the event of new pain, injury, or fall.
|
6 months
|
Multiple Sclerosis Impact Scale (MSIS29 v.2)
Time Frame: 6 months
|
6 months
|
|
Godin Leisure Time Exercise Questionnaire (GLTEQ)
Time Frame: 6 months
|
6 months
|
|
Grip strength measured on hand dynamometer
Time Frame: 6 months
|
6 months
|
|
Timed 25-Foot Walk Test
Time Frame: 6 months
|
6 months
|
|
Timed Up and Go
Time Frame: 6 months
|
6 months
|
|
FIM (R) instrument
Time Frame: 6 months
|
The FIM (R) instrument, data set and impairment codes referenced herein are the property of Uniform Data System for Medical Rehabilitation, a division of UB Foundation Activities, Inc.
|
6 months
|
Hospital Anxiety and Depression Scale
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Katherine Knox, MD, University of Saskatchewan
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Donkers SJ, Nickel D, Paul L, Wiegers SR, Knox KB. Adherence to Physiotherapy-Guided Web-Based Exercise for Persons with Moderate-to-Severe Multiple Sclerosis: A Randomized Controlled Pilot Study. Int J MS Care. 2020 Sep-Oct;22(5):208-214. doi: 10.7224/1537-2073.2019-048. Epub 2020 Jan 8.
- Knox KB, Nickel D, Donkers SJ, Paul L. Physiotherapist and participant perspectives from a randomized-controlled trial of physiotherapist-supported online vs. paper-based exercise programs for people with moderate to severe multiple sclerosis. Disabil Rehabil. 2022 Mar 28:1-7. doi: 10.1080/09638288.2022.2055159. Online ahead of print.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 6, 2017
Primary Completion (Actual)
October 11, 2018
Study Completion (Actual)
October 11, 2018
Study Registration Dates
First Submitted
December 20, 2016
First Submitted That Met QC Criteria
January 30, 2017
First Posted (Estimate)
February 1, 2017
Study Record Updates
Last Update Posted (Actual)
April 13, 2021
Last Update Submitted That Met QC Criteria
April 7, 2021
Last Verified
April 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Bio 16-280
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsRecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
University of California, San FranciscoUnited States Department of DefenseRecruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis (MS) | Multiple Sclerosis Relapse | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis Brain Lesion | Multiple Sclerosis BenignUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Queen Mary University of LondonTakeda Pharmaceuticals International, Inc.RecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
Brigham and Women's HospitalMassachusetts General HospitalRecruitingMultiple Sclerosis | Relapsing Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
University of MinnesotaMallinckrodtTerminatedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
Clinical Trials on Physiotherapist-guided home exercise with web-based support
-
University of Maryland, BaltimoreUniversity of SouthamptonActive, not recruitingStrokeUnited States
-
Cardenal Herrera UniversityCompleted
-
Deutsches Herzzentrum MuenchenRobert-Enke-Stiftung; Institute of Preventive Pediatrics, Technical University... and other collaboratorsCompletedMotor Skills | Congenital Heart Disease | Cardiovascular Prevention | Health Related Physical FitnessGermany
-
Shanghai Zhongshan HospitalNot yet recruiting
-
Chang Gung Memorial HospitalCompleted
-
University of British ColumbiaUniversity of CopenhagenCompleted
-
Lokman Hekim ÜniversitesiCompletedSelf Efficacy | Breast Feeding, ExclusiveTurkey
-
Istanbul University - Cerrahpasa (IUC)Completed
-
University of Nove de JulhoCompletedChronic Obstructive Pulmonary DiseaseBrazil
-
University of PotsdamSwiss Council for Accident Prevention; Prof. Dr. Reto W. Kressig and Dr. Yves...CompletedFall Prevention | Fall Risk FactorsGermany